POLICYBZR Q1 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹1,348 Cr
verified against source
Revenue YoY
33%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
PB Fintech delivered a strong Q1 FY26 with consolidated operating revenue of INR 1,348 crore (up 33% YoY) and PAT of INR 85 crore (vs. INR 19 crore in Q1 FY25), representing a PAT margin expansion from 2% to 6%. Total insurance premium reached INR 6,600 crore (up 36% YoY), led by Health insurance at 65% growth—highest in nine quarters. The core insurance business grew 37% YoY with renewal/trail revenue (12-month rolling) at INR 725 crore, up 43%. Management reiterated a growth-first philosophy, explicitly stating they are "not optimizing for profits" and would "err on the side of taking on extra cost" to capture market share. The 2030 target of INR 1 lakh crore premium remains the North Star. Key risks include credit business headwinds expected through Q2 before recovery in Q3, potential margin pressure from rapid Health growth (fresh business operates at ~-20% EBITDA vs. 75-80% for renewal), and competitive intensity in the POSP segment. Paisabazaar's turnaround remains a work in progress with mutual fund/bonds launch underway.
Colored figures show movement against the previous available record.
Guidance to track
- Management reiterated its long-term goal of reaching INR 1 lakh crore of insurance premium by 2030, viewing this as the "North Pole" goal over near-term profitability.
- Current insurance revenue growth of 47% is expected to moderate to approximately 45% range, sustaining double-digit expansion over the medium term.
- Directionally, new initiatives (POSP, UAE, Corporate) should be "very close to zero" from EBITDA perspective by next year, with long-term sustainable margin around 5%.
- Paisabazaar expects credit disbursals and quality to inflect positively from Q3, after using Q1-Q2 to build backend operations and digital integrations.
- Effective tax rate expected to remain around 8-10% due to accumulated carry-forward losses benefit, consistent with long-term profitability guidance framework.
Risks flagged
- Paisabazaar acknowledged being on "the opposite side" of high approval rates from last year. Expects bottoming out with recovery only in Q3, creating continued drag on consolidated profitability.
- Analyst Suresh Ganapathy raised concern that at 25% market share in term and ~15% in Health with industry growth constrained to 15%, sustaining 30%+ growth becomes mathematically challenging. Management deflected by saying they are in "market creation" not "market share" game.
- As Health vintage grows, renewal economics could deteriorate (Health renewal rates lower than term). Management acknowledged this but stated no change seen yet in renewal take rates at 6.9%.
- Despite representing 80-85% of the insurance market, Policybazaar's savings share remains at ~2% (5% ex-LIC), flat for some time. Management cited product complexity and consumer education challenges, acknowledging it "takes time."
- Fresh Health business operates at ~-20% EBITDA vs. 75-80% for renewal business. Rapid Health growth is creating margin headwind. Management explicitly stated Health growth "is not helping short-term profitability" but they will continue regardless.
Key quotes
- Our focus for the time being is entirely on growth. Yes, we will deliver profits, but there will be an outcome rather than... We are clearly not optimizing for profits right now.
- Whenever there's a call we have to make on can we make this investment and maybe there's a doubt that it will help us in terms of growth or not, we will more often than not make that investment and err on the side of having taken on extra cost and not being able to deliver the growth rather than having the growth opportunity and not being able to deliver because we did not take on a particular cost.
- We are not in the market share game... We are in the market creation game. Our belief is Policybazaar alone will be bigger than that market projection over the next 10 years.
- 82% of the business that we did was from new customers, new to insurance customers. They may have had a corporate policy. They did not have a retail Health insurance policy.
Research modules
